查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1610244

藥用輔料市場：按類型、配方、功能和最終用戶分類 - 全球預測 2025-2030

Pharmaceutical Excipient Market by Type (Inorganic, Organic), Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations), Function, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥用輔料市場價值為86.2億美元，預計2024年將達到92.2億美元，複合年成長率為7.62%，到2030年將達到144.2億美元。

藥用輔料是與藥物活性成分（API）結合的惰性物質，在促進藥物穩定性、生物有效性和遞送方面發揮重要作用。它們在各種藥物製劑中至關重要，提供結合、包衣、增溶和保存等功能。賦形劑的用途多種多樣，包括口服製劑、外用製劑、腸胃外製劑和吸入製劑，主要最終使用領域包括醫院、診所和研究機構。藥用輔料市場的成長主要是由製藥業的擴張、藥物批准數量的增加以及藥物輸送系統的顯著進步所推動的。此外，對口服藥物和技術先進的多功能賦形劑的需求不斷增加，為市場擴張鋪平了道路。然而，市場面臨嚴格的監管準則和開拓新輔料相關的高成本等挑戰，這可能會阻礙成長。也存在一些限制，例如賦形劑與藥物相互作用的潛在風險以及影響製劑一致性的賦形劑特性的變化。

主要市場統計
基準年[2023] 86.2億美元
預計年份 [2024] 92.2億美元
預測年份 [2030] 144.2億美元
複合年成長率（%） 7.62%

最新的商機包括對生物製藥的日益關注和個人化醫療的日益採用。環保意識的提高繼續推動對天然和永續賦形劑的探索，創造了一個主要的創新領域。探索與生物技術公司在胜肽和蛋白質配方賦形劑開發方面的合作可以進一步推動成長。共加工賦形劑和多功能賦形劑的探索也可能提供競爭優勢。該市場充滿活力，其特點是技術快速進步和下一代輔料的強大管道。企業應策略性地將研發投資重點放在創新輔料類型和配方上，並利用合作研究來提高能力並滿足現代藥物配方的多樣化需求。透過識別輔料需求未滿足的利基市場並相應地客製化您的解決方案，您可以確保重要的市場地位。

市場動態：揭示快速發展的藥用輔料市場的關鍵市場洞察

供需的動態交互作用正在改變藥用輔料市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球癌症及其他慢性病和感染疾病率不斷上升
    • 製藥業的成長加上對學名藥藥和孤兒藥的強勁需求
    • 重點生產多功能輔料
  • 市場限制因素
    • 製造先進輔料的高成本
  • 市場機會
    • 賦形劑奈米技術的進展
    • 持續研究並開發具有多種特性的賦形劑（生物基）
  • 市場挑戰
    • 更嚴格的法規和日益成長的輔料相容性問題

波特五力：駕馭藥用輔料市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥用輔料市場的外部影響

外部宏觀環境因素對藥用輔料市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解藥用輔料市場競爭狀況

對藥用輔料市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣藥用輔料市場供應商績效評估

FPNV定位矩陣是評估藥用輔料市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議描繪藥用輔料市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，藥用輔料市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地癌症、其他慢性病和感染疾病的發生率正在上升
      • 製藥業的成長以及對學名藥藥和孤兒藥的強勁需求
      • 專注於多功能輔料製造
    • 抑制因素
      • 製造先進輔料的高成本
    • 機會
      • 輔料奈米技術的技術進步
      • 不斷研發各種特性的輔料（生物基）
    • 任務
      • 更嚴格的法規和日益增多的添加劑相容性問題
  • 市場區隔分析
    • 類型：有機添加劑的潛在需求和用途
    • 製劑：由於給藥方便，口服製劑的需求量大
    • 功能：被覆劑為藥物提供物理和化學保護
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章藥用輔料市場：依類型

  • 無機的
    • 碳酸鈣
    • 磷酸鈣
    • 硫酸鈣
    • 岩鹽
    • 金屬氧化物
  • 有機的
    • 碳水化合物
      • 纖維素
      • 澱粉
      • 醣類
    • 油脂化學品
      • 脂醇類
      • 甘油
      • 礦物硬脂酸鹽
    • 石化產品
      • 丙烯酸聚合物
      • 乙二醇
      • 丁二醇
      • 二伸乙甘醇
      • 乙二醇
      • 己二醇
      • 宏觀目標
      • 微量乙二醇
      • 丙二醇
      • 礦物碳氫化合物
      • 聚維酮
    • 蛋白質

第7章以劑型分類的藥用輔料市場

  • 口服製劑
    • 硬明膠膠囊
    • 液體配方
    • 軟明膠膠囊
    • 藥片
  • 腸外製劑
  • 局部製劑

第8章藥用輔料市場：依功能分類

  • 活頁夾
  • 被覆劑
  • 著色劑
  • 崩壞
  • 乳化劑
  • 填充劑和稀釋劑
  • 調味劑/甜味劑
  • 潤滑劑和潤滑劑
  • 防腐劑
  • 懸浮劑和黏稠劑

第9章藥用輔料市場：依最終用戶分類

  • 生物製藥公司
  • 契約製造組織
  • 製藥公司
  • 研究室

第10章美洲藥用輔料市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥用輔料市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲藥用輔料市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 贏創的新型噴霧乾燥設施增強了口服賦形劑的全球供應和永續性
    • 羅蓋特對 IFF Pharma Solutions 的策略性收購增強了其在給藥解決方案和輔料市場的全球影響力
    • 旭化成利用低亞硝酸鹽 Ceolus MCC 賦形劑提高藥物安全性並擴大生產
    • 羅蓋特宣布抗濕新技術
    • 科萊恩在巴塞隆納 CPHI 上展示新的添加劑系列，以提高 API 的穩定性和溶解度
    • BASF與 IFF 合作開發虛擬製藥助理平台 ZoomLab
    • 路博潤向 Wellton Pharma 授權屢獲殊榮的 Apisolex 賦形劑開發新的癌症治療方法
    • 安瑞安宣布策略投資擴張至高付加醫藥原料領域
    • DFE Pharma 推出 Lactohale 400 擴大吸入產品組合
    • 贏創將與美國政府合作，投資2.2億美元在美國建造一座新的脂質生產設施，以基於mRNA的療法。
    • 路博潤推出 Apisolex 技術
    • UniverSolutions 透過與亞什蘭簽訂新的分銷協議擴大藥品產品組合
    • 阿澤雷斯透過擴大與 Rocket 的合作夥伴關係加強在印度的製藥業務
    • 羅蓋特完全收購佳潔士纖維素，擴大其全球植物來源輔料產品組合
  • 戰略分析和建議

公司名單

  • ABITEC Corporation
  • Actylis
  • Archer Daniels Midland Company
  • ARMOR PROTEINES SAS
  • Asahi Kasei Corporation
  • Ashland Inc.
  • BASF SE
  • BIOGRUND GmbH
  • Chemische Fabrik Budenheim KG
  • Clariant AG
  • Colorcon Inc.
  • Corel Pharma Chem Private Limited
  • Croda International Plc
  • Darling Ingredients, Inc.
  • DFE Pharma GmbH & Co KG
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • GATTEFOSSE SAS
  • Innophos Holdings, Inc.
  • International Flavors & Fragrances Inc.
  • JRS PHARMA GmbH+Co. KG
  • Kerry Group PLC
  • Lipoid GmbH
  • Lubrizol Corporation
  • L'AIR LIQUIDE SA
  • Mallinckrodt plc
  • MEGGLE GmbH & Co. KG
  • Merck KGaA
  • Nagase & Co., Ltd.
  • Nipon Soda Co., Ltd.
  • NOF Corporation
  • Omya International AG
  • Peter Greven GmbH & Co. KG
  • RT Vanderbilt Holding Company, Inc.
  • Roquette Freres SA
  • Shin-Etsu Chemical Co., Ltd.
  • Solvay SA
  • SPI Pharma, Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-030EE48515E2

The Pharmaceutical Excipient Market was valued at USD 8.62 billion in 2023, expected to reach USD 9.22 billion in 2024, and is projected to grow at a CAGR of 7.62%, to USD 14.42 billion by 2030.

Pharmaceutical excipients are inactive substances formulated alongside the active pharmaceutical ingredient (API) of a medication, serving critical roles in promoting stability, bioavailability, and delivery of the drug. They are essential in various drug formulations, offering functionalities such as binding, coating, solubilizing, and preserving. Excipients are utilized across several applications, including oral, topical, parenteral, and inhalation preparations, with key end-use sectors comprising hospitals, clinics, and research institutions. The growth of the pharmaceutical excipient market is primarily driven by the expanding pharmaceutical sector, increased drug approvals, and significant advancements in drug delivery systems. Additionally, the rise in demand for oral medications and technologically advanced multifunctional excipients is opening avenues for market expansion. However, the market faces challenges, such as stringent regulatory guidelines and high costs associated with the development of new excipients, which can hinder growth. Limitations include potential risks of excipient-drug interactions and variability in excipient characteristics, impacting formulation consistency.

KEY MARKET STATISTICS
Base Year [2023] USD 8.62 billion
Estimated Year [2024] USD 9.22 billion
Forecast Year [2030] USD 14.42 billion
CAGR (%) 7.62%

Among the latest opportunities are the rising focus on biopharmaceuticals and the growing implementation of personalized medicine, which necessitates novel excipient development to cater to unique delivery and stability needs. There's a continuous push towards natural and sustainable excipients due to growing environmental awareness, providing an excellent area for innovation. Exploring collaborations with biotech firms for excipient development in peptide and protein formulations can further drive growth. Research into co-processed and multifunctional excipients can also yield competitive advantages. The market is highly dynamic, characterized by rapid technological advancements and a robust pipeline of next-generation excipients. Businesses should strategically focus on R&D investments in innovative excipient types and formulations, leveraging collaborations to enhance capabilities and meet the diverse demands of modern drug formulations. Identifying niche markets with unmet excipient needs and tailoring solutions accordingly can secure a significant market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Excipient Market

The Pharmaceutical Excipient Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of cancer and other chronic and infectious diseases worldwide
    • Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
    • Significant emphasis on the production of multifunctional excipients
  • Market Restraints
    • High cost associated with the production of advanced excipient
  • Market Opportunities
    • Technological advancements in nanotechnology for excipients
    • Ongoing research and development of excipients with numerous properties (Biobased)
  • Market Challenges
    • Increasing regulatory stringency and issues regarding the compatibility of excipients

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Excipient Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Excipient Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Excipient Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Excipient Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Excipient Market

A detailed market share analysis in the Pharmaceutical Excipient Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Excipient Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Excipient Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Excipient Market

A strategic analysis of the Pharmaceutical Excipient Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Archer Daniels Midland Company, ARMOR PROTEINES S.A.S., Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG, DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc., International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L'AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, R.T. Vanderbilt Holding Company, Inc., Roquette Freres S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Excipient Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inorganic and Organic. The Inorganic is further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic is further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones. The Glycols is further studied across Butylene Glycol, Diethylene Glycol, Ethylene Glycol, Hexylene Glycol, Macrogol, Microglycol, and Propylene Glycol.
  • Based on Formulation, market is studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Hard Gelatin Capsules, Liquid Formulations, Soft Gelatin Capsules, and Tablets.
  • Based on Function, market is studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
  • Based on End-User, market is studied across Biopharmaceutical Companies, Contract Manufacturing Organizations, Pharmaceutical Companies, and Research Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
      • 5.1.1.2. Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
      • 5.1.1.3. Significant emphasis on the production of multifunctional excipients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the production of advanced excipient
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in nanotechnology for excipients
      • 5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Potential demand and utilization of organic excipients
    • 5.2.2. Formulation: Significant demand for oral formulations owing to its convenient drug delivery
    • 5.2.3. Function: Coating agents provide physical and chemical protection for the drug
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Excipient Market, by Type

  • 6.1. Introduction
  • 6.2. Inorganic
    • 6.2.1. Calcium Carbonate
    • 6.2.2. Calcium Phosphate
    • 6.2.3. Calcium Sulfate
    • 6.2.4. Halites
    • 6.2.5. Metal Oxides
  • 6.3. Organic
    • 6.3.1. Carbohydrates
      • 6.3.1.1. Cellulose
      • 6.3.1.2. Starch
      • 6.3.1.3. Sugars
    • 6.3.2. Oleochemicals
      • 6.3.2.1. Fatty Alcohols
      • 6.3.2.2. Glycerin
      • 6.3.2.3. Mineral Stearates
    • 6.3.3. Petrochemicals
      • 6.3.3.1. Acrylic Polymers
      • 6.3.3.2. Glycols
      • 6.3.3.2.1. Butylene Glycol
      • 6.3.3.2.2. Diethylene Glycol
      • 6.3.3.2.3. Ethylene Glycol
      • 6.3.3.2.4. Hexylene Glycol
      • 6.3.3.2.5. Macrogol
      • 6.3.3.2.6. Microglycol
      • 6.3.3.2.7. Propylene Glycol
      • 6.3.3.3. Mineral Hydrocarbons
      • 6.3.3.4. Povidones
    • 6.3.4. Proteins

7. Pharmaceutical Excipient Market, by Formulation

  • 7.1. Introduction
  • 7.2. Oral Formulations
    • 7.2.1. Hard Gelatin Capsules
    • 7.2.2. Liquid Formulations
    • 7.2.3. Soft Gelatin Capsules
    • 7.2.4. Tablets
  • 7.3. Parenteral Formulations
  • 7.4. Topical Formulations

8. Pharmaceutical Excipient Market, by Function

  • 8.1. Introduction
  • 8.2. Binders
  • 8.3. Coating Agents
  • 8.4. Colorants
  • 8.5. Disintegrants
  • 8.6. Emulsifying Agents
  • 8.7. Fillers & Diluents
  • 8.8. Flavoring Agents & Sweeteners
  • 8.9. Lubricants & Glidants
  • 8.10. Preservatives
  • 8.11. Suspending & Viscosity Agents

9. Pharmaceutical Excipient Market, by End-User

  • 9.1. Introduction
  • 9.2. Biopharmaceutical Companies
  • 9.3. Contract Manufacturing Organizations
  • 9.4. Pharmaceutical Companies
  • 9.5. Research Laboratories

10. Americas Pharmaceutical Excipient Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmaceutical Excipient Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Excipient Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Evonik's new spray drying facility enhances global supply and sustainability of oral excipients
    • 13.3.2. Roquette's strategic acquisition of IFF Pharma Solutions to bolster global influence in drug delivery solutions and excipients market
    • 13.3.3. Asahi Kasei enhances pharmaceutical safety with low-nitrite Ceolus MCC excipient and expanded production
    • 13.3.4. Roquette Introduces New Advancement in Moisture Protection
    • 13.3.5. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
    • 13.3.6. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
    • 13.3.7. Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
    • 13.3.8. Ingredion Announces Strategic Investments Expanding Into High-Value Pharmaceutical Ingredients
    • 13.3.9. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
    • 13.3.10. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
    • 13.3.11. Lubrizol Launches Apisolex Technology
    • 13.3.12. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
    • 13.3.13. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
    • 13.3.14. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABITEC Corporation
  • 2. Actylis
  • 3. Archer Daniels Midland Company
  • 4. ARMOR PROTEINES S.A.S.
  • 5. Asahi Kasei Corporation
  • 6. Ashland Inc.
  • 7. BASF SE
  • 8. BIOGRUND GmbH
  • 9. Chemische Fabrik Budenheim KG
  • 10. Clariant AG
  • 11. Colorcon Inc.
  • 12. Corel Pharma Chem Private Limited
  • 13. Croda International Plc
  • 14. Darling Ingredients, Inc.
  • 15. DFE Pharma GmbH & Co KG
  • 16. DuPont de Nemours, Inc.
  • 17. Evonik Industries AG
  • 18. Fuji Chemical Industries Co., Ltd.
  • 19. GATTEFOSSE SAS
  • 20. Innophos Holdings, Inc.
  • 21. International Flavors & Fragrances Inc.
  • 22. JRS PHARMA GmbH + Co. KG
  • 23. Kerry Group P.L.C.
  • 24. Lipoid GmbH
  • 25. Lubrizol Corporation
  • 26. L'AIR LIQUIDE S.A.
  • 27. Mallinckrodt plc
  • 28. MEGGLE GmbH & Co. KG
  • 29. Merck KGaA
  • 30. Nagase & Co., Ltd.
  • 31. Nipon Soda Co., Ltd.
  • 32. NOF Corporation
  • 33. Omya International AG
  • 34. Peter Greven GmbH & Co. KG
  • 35. R.T. Vanderbilt Holding Company, Inc.
  • 36. Roquette Freres S.A.
  • 37. Shin-Etsu Chemical Co., Ltd.
  • 38. Solvay S.A.
  • 39. SPI Pharma, Inc.
  • 40. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL EXCIPIENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BUTYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DIETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HEXYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MACROGOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MICROGLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROPYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 72. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 85. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 86. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 87. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 88. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 89. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 98. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 100. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 111. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 173. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 184. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 185. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 186. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 195. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 196. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 197. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 198. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 199. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 206. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 207. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 208. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 209. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 210. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 211. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 212. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 217. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 218. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 220. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 222. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 228. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 229. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 230. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 231. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 232. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 234. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 250. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 251. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 252. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 253. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 254. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 256. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 261. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 262. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 263. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 264. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 265. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 267. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 268. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 272. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 273. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 274. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 275. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 276. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 277. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 278. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 291. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 293. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 294. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 295. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 296. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 297. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 298. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 299. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 300. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 301. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 304. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 305. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 306. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 307. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 308. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 309. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 310. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 311. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 312. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 313. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 315. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 316. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 317. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 318. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 319. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 320. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 321. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
  • TABLE 322. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 323. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
  • TABLE 326. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
  • TABLE 327. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 328. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 329. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
  • TABLE 330. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
  • TABLE 331. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 332. FRANCE PHARMACEUTICAL EX